目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 VETERINARY VACCINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: MERCK & CO., IN.
FIGURE 8 MARKET: SUPPLY-SIDE ANALYSIS OF LEADING COMPANIES (2021)
FIGURE 9 MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)
FIGURE 10 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 MARKET: RISK ASSESSMENT ANALYSIS
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 13 VETERINARY VACCINES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 15 MARKET, BY DISEASE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 MARKET, BY ROUTE OF ADMINISTRATION, 2022 VS. 2027 (USD MILLION)
FIGURE 17 MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 18 MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 49)
4.1 VETERINARY VACCINES MARKET OVERVIEW
FIGURE 19 RISING GROWTH IN COMPANION ANIMAL POPULATION TO DRIVE MARKET
4.2 ASIA PACIFIC: MARKET, BY TECHNOLOGY (2021)
FIGURE 20 LIVE ATTENUATED VACCINES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
4.4 MARKET, BY REGION
FIGURE 22 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growth in companion animal population
TABLE 3 EUROPEAN PET POPULATION, BY ANIMAL, 2016-2022 (MILLION)
5.2.1.2 Rising incidence of zoonotic diseases
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009-2019)
5.2.1.3 Initiatives by various government agencies and animal associations
5.2.1.4 Rising demand for animal-derived food products
TABLE 5 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK (DEVELOPED VS. EMERGING MARKETS)
TABLE 6 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 7 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
5.2.1.5 Growing demand for pet insurance and rising animal health expenditure
TABLE 8 US: AVERAGE PREMIUMS PAID (2019-2021)
FIGURE 25 CANADA: AVERAGE ANNUAL PREMIUMS, 2017-2021
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010-2021
TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020 VS. 2021 (USD BILLION)
TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012-2021 (USD MILLION)
5.2.2 RESTRAINTS
5.2.2.1 High storage cost of vaccines
5.2.2.2 Rising pet care costs
FIGURE 27 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.3.2 Untapped emerging markets
5.2.4 CHALLENGES
5.2.4.1 Inadequate surveillance and reporting systems
5.2.4.2 Lack of animal healthcare awareness in emerging countries
5.3 INDUSTRY TRENDS
5.3.1 GROWING SCALE OF VETERINARY BUSINESSES
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 US
5.4.3 EUROPE
5.4.4 REST OF THE WORLD
5.5 VALUE CHAIN ANALYSIS
FIGURE 28 MARKET: VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 29 MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 30 MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY VACCINES
FIGURE 31 PATENT PUBLICATION TRENDS (JANUARY 2013-MARCH 2023)
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 32 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY VACCINES PATENTS (JANUARY 2013-MARCH 2023)
FIGURE 33 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY VACCINES PATENTS (JANUARY 2013-MARCH 2023)
5.10 TECHNOLOGY ANALYSIS
5.11 INDICATIVE PRICING MODEL ANALYSIS
TABLE 13 AVERAGE SELLING PRICE OF VETERINARY VACCINES
5.11.1 AVERAGE SELLING PRICE TRENDS
5.12 KEY CONFERENCES AND EVENTS (2023-2025)
TABLE 14 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY VACCINES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY VACCINES
5.13.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR VETERINARY VACCINES
TABLE 16 KEY BUYING CRITERIA FOR VETERINARY VACCINES

6 VETERINARY VACCINES MARKET, BY TYPE (Page No. - 81)
6.1 INTRODUCTION
TABLE 17 MARKET, BY TYPE, 2020-2027 (USD MILLION)
6.2 LIVESTOCK VACCINES
TABLE 18 LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 19 LIVESTOCK VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.1 BOVINE VACCINES
6.2.1.1 Bovine vaccines segment to dominate market
TABLE 20 BOVINE VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.2.2 SMALL RUMINANT VACCINES
6.2.2.1 Small ruminant vaccines segment to register lower growth in livestock vaccines market
TABLE 21 SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3 PORCINE VACCINES
6.3.1 SECOND-LARGEST MARKET DURING FORECAST PERIOD
TABLE 22 PORCINE VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.4 POULTRY VACCINES
6.4.1 INCREASED PRODUCTION AND REARING OF POULTRY TO DRIVE MARKET GROWTH
TABLE 23 POULTRY VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 COMPANION ANIMAL VACCINES
TABLE 24 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 25 COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.1 CANINE VACCINES
6.5.1.1 Canine vaccines segment to dominate companion animal vaccines market during forecast period
TABLE 26 CANINE VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5.2 FELINE VACCINES
6.5.2.1 Rising prevalence of zoonotic diseases to drive demand for feline vaccines
TABLE 27 FELINE VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.6 AQUACULTURE VACCINES
6.6.1 VACCINATION PLAYS CRUCIAL ROLE IN COMMERCIAL FISH FARMING
TABLE 28 AQUACULTURE VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.7 OTHER ANIMAL VACCINES
TABLE 29 OTHER COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 VETERINARY VACCINES MARKET, BY DISEASE (Page No. - 93)
7.1 INTRODUCTION
TABLE 30 MARKET, BY DISEASE, 2020-2027 (USD MILLION)
7.2 PORCINE DISEASES
7.2.1 PORCINE CIRCOVIRUS II TO ACCOUNT FOR LARGEST SHARE OF PORCINE VACCINES MARKET
TABLE 31 PORCINE VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 32 PORCINE DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 POULTRY DISEASES
7.3.1 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF POULTRY VACCINES MARKET
TABLE 33 POULTRY VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 34 POULTRY DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 LIVESTOCK DISEASES
TABLE 35 LIVESTOCK VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 36 LIVESTOCK DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.1 BOVINE DISEASES
7.4.1.1 Foot-and-mouth disease segment to account for largest share of bovine vaccines market
TABLE 37 BOVINE VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 38 BOVINE DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.4.2 SMALL RUMINANT DISEASES
7.4.2.1 Clostridial disease segment to account for largest share of small ruminant vaccines market
TABLE 39 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 40 SMALL RUMINANT DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 COMPANION ANIMAL DISEASES
TABLE 41 COMPANION ANIMAL VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 42 COMPANION ANIMAL DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.5.1 CANINE DISEASES
7.5.1.1 Canine rabies segment to account for largest share of canine vaccines market
TABLE 43 CANINE VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 44 CANINE DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.5.2 FELINE DISEASES
7.5.2.1 Feline viral rhinotracheitis segment to grow at highest CAGR during forecast period
TABLE 45 FELINE VACCINES MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 46 FELINE DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.6 AQUACULTURE DISEASES
7.6.1 VACCINES IN AQUACULTURE MAJORLY DEVELOPED FOR SALMONIDS, CATFISH, AND SHRIMP
TABLE 47 AQUACULTURE DISEASES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY (Page No. - 107)
8.1 INTRODUCTION
TABLE 48 MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
8.2 LIVE ATTENUATED VACCINES
8.2.1 LIVE ATTENUATED VACCINES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
TABLE 49 LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 INACTIVATED VACCINES
8.3.1 RISING NEED TO DEVELOP ARTIFICIAL IMMUNITY AGAINST DISEASES FROM NON-LIVING PATHOGENS TO DRIVE GROWTH
TABLE 50 INACTIVATED VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4 TOXOID VACCINES
8.4.1 TOXOID VACCINES USED WHEN BACTERIAL TOXINS CAUSE ILLNESS
TABLE 51 TOXOID VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.5 RECOMBINANT VACCINES
8.5.1 ADVANTAGES ASSOCIATED WITH RECOMBINANT VACCINES TO DRIVE DEMAND
TABLE 52 RECOMBINANT VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.6 OTHER VACCINES
TABLE 53 OTHER VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

9 VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION (Page No. - 114)
9.1 INTRODUCTION
TABLE 54 ROUTES OF ADMINISTRATION OF MAJOR VETERINARY VACCINES
TABLE 55 MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
9.2 INJECTABLE VACCINES
9.2.1 INJECTABLE VACCINES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 56 INJECTABLE VETERINARY VACCINE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9.3 ORAL VACCINES
9.3.1 ORAL VACCINES MAKE IMMUNIZATION EASIER
TABLE 57 ORAL VETERINARY VACCINE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
9.4 INTRANASAL/SPRAY VACCINES
9.4.1 LOW COST OF INTRANASAL/SPRAY VACCINES TO SUPPORT MARKET GROWTH
TABLE 58 INTRANASAL/SPRAY VETERINARY VACCINE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

10 VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL (Page No. - 121)
10.1 INTRODUCTION
TABLE 59 MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
10.2 VETERINARY HOSPITALS
10.2.1 VETERINARY HOSPITALS FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT IN MARKET
TABLE 60 US: VETERINARY VISIT EXPENSES FOR CATS AND DOGS
TABLE 61 MARKET FOR VETERINARY HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
10.3 VETERINARY CLINICS
10.3.1 INCREASING NUMBER OF PRIVATE CLINICAL PRACTICES TO SUPPORT MARKET GROWTH
TABLE 62 NUMBER OF PRIVATE CLINICAL PRACTICES, BY COUNTRY, 2019 VS. 2021
TABLE 63 MARKET FOR VETERINARY CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
10.4 RETAIL PHARMACIES
10.4.1 EASY ACCESSIBILITY TO PHARMACEUTICALS TO SUPPORT MARKET GROWTH
TABLE 64 MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020-2027 (USD MILLION)

11 VETERINARY VACCINES MARKET, BY REGION (Page No. - 127)
11.1 INTRODUCTION
TABLE 65 MARKET, BY REGION, 2020-2027 (USD MILLION)
11.2 ASIA PACIFIC
11.2.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 36 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 71 ASIA PACIFIC: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 72 ASIA PACIFIC: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 73 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 74 ASIA PACIFIC: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.2 CHINA
11.2.2.1 China to dominate Asia Pacific veterinary vaccines market
TABLE 76 CHINA: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 77 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 78 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 79 CHINA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 80 CHINA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 81 CHINA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 82 CHINA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 83 CHINA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 84 CHINA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.3 JAPAN
11.2.3.1 Increasing expenditure on pet healthcare to drive market growth
TABLE 85 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 86 JAPAN: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 87 JAPAN: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 88 JAPAN: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 89 JAPAN: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 90 JAPAN: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 91 JAPAN: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 92 JAPAN: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 93 JAPAN: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 94 JAPAN: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.4 INDIA
11.2.4.1 Dearth of veterinarians to restrain market growth
TABLE 95 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 96 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 97 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 98 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 99 INDIA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 100 INDIA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 101 INDIA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 102 INDIA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 103 INDIA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 104 INDIA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.5 AUSTRALIA
11.2.5.1 Increase in pet ownership to support market growth
TABLE 105 AUSTRALIA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 106 AUSTRALIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 107 AUSTRALIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 108 AUSTRALIA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 109 AUSTRALIA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 110 AUSTRALIA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 111 AUSTRALIA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 112 AUSTRALIA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 113 AUSTRALIA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.6 SOUTH KOREA
11.2.6.1 Growing companion animal population to drive market growth
TABLE 114 SOUTH KOREA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 115 SOUTH KOREA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 116 SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 117 SOUTH KOREA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 118 SOUTH KOREA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 119 SOUTH KOREA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 120 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 121 SOUTH KOREA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 122 SOUTH KOREA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.7 THAILAND
11.2.7.1 Growth of pork and poultry industry to drive market
TABLE 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 126 THAILAND: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 127 THAILAND: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 128 THAILAND: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 129 THAILAND: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 130 THAILAND: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 131 THAILAND: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.2.8 REST OF ASIA PACIFIC
TABLE 132 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.3 NORTH AMERICA
FIGURE 37 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
11.3.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 38 NORTH AMERICA: VETERINARY VACCINES MARKET SNAPSHOT
TABLE 141 NORTH AMERICA: MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 143 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 144 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 145 NORTH AMERICA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 146 NORTH AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 147 NORTH AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 148 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 149 NORTH AMERICA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 150 NORTH AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.3.2 US
11.3.2.1 US to dominate North American veterinary vaccines market
FIGURE 39 US: POPULATION OF DOGS, 2012-2020 (MILLION)
FIGURE 40 US: EXPENDITURE ON VET VISITS
TABLE 151 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020
FIGURE 41 INCOME OF VETERINARIANS IN US, 2017-2021
FIGURE 42 NUMBER OF VETERINARIANS IN US, 2016-2020
TABLE 152 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014-2020
TABLE 153 US: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 154 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 155 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 156 US: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 157 US: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 158 US: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 159 US: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 160 US: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 161 US: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.3.3 CANADA
11.3.3.1 Rising pet and livestock populations to support market growth
FIGURE 43 CANADA: COMPANION ANIMAL POPULATION, 2016-2020 (MILLION)
TABLE 162 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 163 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 164 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 165 CANADA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 166 CANADA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 167 CANADA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 168 CANADA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 169 CANADA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 170 CANADA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4 EUROPE
11.4.1 EUROPE: RECESSION IMPACT
TABLE 171 EUROPE: VETERINARY VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 172 EUROPE: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 173 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 174 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 175 EUROPE: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 176 EUROPE: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 177 EUROPE: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 178 EUROPE: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 179 EUROPE: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 180 EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.2 GERMANY
11.4.2.1 Germany to dominate European veterinary vaccines market
TABLE 181 GERMANY: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 182 GERMANY: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 183 GERMANY: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 184 GERMANY: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 185 GERMANY: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 186 GERMANY: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 187 GERMANY: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 188 GERMANY: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 189 GERMANY: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.3 UK
11.4.3.1 Growing pet adoption to drive demand for veterinary vaccines
TABLE 190 UK: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 191 UK: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 192 UK: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 193 UK: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 194 UK: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 195 UK: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 196 UK: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 197 UK: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 198 UK: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.4 FRANCE
11.4.4.1 Rising pet ownership to support market growth
TABLE 199 FRANCE: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 200 FRANCE: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 201 FRANCE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 202 FRANCE: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 203 FRANCE: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 204 FRANCE: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 205 FRANCE: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 206 FRANCE: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 207 FRANCE: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.5 ITALY
11.4.5.1 Increasing outbreaks of diseases to support market growth
TABLE 208 ITALY: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 209 ITALY: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 210 ITALY: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 211 ITALY: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 212 ITALY: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 213 ITALY: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 214 ITALY: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 215 ITALY: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 216 ITALY: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.6 SPAIN
11.4.6.1 Increase in number of veterinary practices to drive market growth
TABLE 217 SPAIN: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 218 SPAIN: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 219 SPAIN: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 220 SPAIN: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 221 SPAIN: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 222 SPAIN: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 223 SPAIN: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 224 SPAIN: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 225 SPAIN: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.4.7 REST OF EUROPE
TABLE 226 REST OF EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 227 REST OF EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 228 REST OF EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 229 REST OF EUROPE: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 230 REST OF EUROPE: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 231 REST OF EUROPE: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 232 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 233 REST OF EUROPE: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 234 REST OF EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 235 LATIN AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 236 LATIN AMERICA: MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 237 LATIN AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 238 LATIN AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 239 LATIN AMERICA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 240 LATIN AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 241 LATIN AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 242 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 243 LATIN AMERICA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 244 LATIN AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Well-established and rapidly growing livestock industry to promote growth
TABLE 245 BRAZIL: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 246 BRAZIL: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 247 BRAZIL: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 248 BRAZIL: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 249 BRAZIL: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 250 BRAZIL: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 251 BRAZIL: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 252 BRAZIL: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 253 BRAZIL: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Mexico to continue to be second-largest pet care market in Latin America during forecast period
TABLE 254 MEXICO: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 255 MEXICO: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 256 MEXICO: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 257 MEXICO: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 258 MEXICO: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 259 MEXICO: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 260 MEXICO: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 261 MEXICO: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 262 MEXICO: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 263 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 264 REST OF LATIN AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 265 REST OF LATIN AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 266 REST OF LATIN AMERICA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 267 REST OF LATIN AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 268 REST OF LATIN AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 269 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 270 REST OF LATIN AMERICA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 271 REST OF LATIN AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH
TABLE 272 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 273 MIDDLE EAST & AFRICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 274 MIDDLE EAST & AFRICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 275 MIDDLE EAST & AFRICA: MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 276 MIDDLE EAST & AFRICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 277 MIDDLE EAST & AFRICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
TABLE 279 MIDDLE EAST & AFRICA: MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 280 MIDDLE EAST & AFRICA: MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 217)
12.1 OVERVIEW
12.2 STRATEGIES ADOPTED BY KEY PLAYERS (JANUARY 2019 TO MARCH 2023)
FIGURE 44 KEY PLAYER STRATEGIES
12.3 REVENUE SHARE ANALYSIS OF TOP 5 PLAYERS
FIGURE 45 VETERINARY VACCINES MARKET: REVENUE SHARE ANALYSIS OF TOP PLAYERS (2017−2021)
12.4 MARKET SHARE ANALYSIS
FIGURE 46 MARKET SHARE, BY KEY PLAYER (2021)
12.5 COMPANY FOOTPRINT
TABLE 281 MARKET: BY TYPE
TABLE 282 MARKET: BY DISEASE
TABLE 283 MARKET: BY TECHNOLOGY
TABLE 284 MARKET: BY ROUTE OF ADMINISTRATION
TABLE 285 MARKET: BY DISTRIBUTION CHANNEL
12.6 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 286 MARKET: REGIONAL REVENUE MIX
12.7 COMPANY EVALUATION QUADRANT
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
FIGURE 47 MARKET: COMPANY EVALUATION QUADRANT (2021)
12.8 STARTUPS/SMES EVALUATION QUADRANT
12.8.1 PROGRESSIVE COMPANIES
12.8.2 DYNAMIC COMPANIES
12.8.3 STARTING BLOCKS
12.8.4 RESPONSIVE COMPANIES
FIGURE 48 MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES (2021)
12.9 COMPETITIVE BENCHMARKING
TABLE 287 VETERINARY VACCINES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
12.1 COMPETITIVE SITUATION AND TRENDS
12.10.1 PRODUCT LAUNCHES & APPROVALS
TABLE 288 PRODUCT LAUNCHES & APPROVALS
12.10.2 DEALS
TABLE 289 DEALS
12.10.3 OTHER DEVELOPMENTS
TABLE 290 OTHER DEVELOPMENTS

13 COMPANY PROFILES (Page No. - 234)
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY PLAYERS
13.1.1 ZOETIS, INC.
TABLE 291 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 49 ZOETIS, INC.: COMPANY SNAPSHOT (2022)
13.1.2 MERCK & CO., INC.
TABLE 292 MERCK & CO., INC.: BUSINESS OVERVIEW
FIGURE 50 MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
13.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
TABLE 293 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS OVERVIEW
FIGURE 51 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021)
13.1.4 ELANCO ANIMAL HEALTH
TABLE 294 ELANCO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 52 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT (2021)
13.1.5 VIRBAC
TABLE 295 VIRBAC: BUSINESS OVERVIEW
FIGURE 53 VIRBAC: COMPANY SNAPSHOT (2021)
13.1.6 CEVA SANTÉ ANIMALE
TABLE 296 CEVA SANTÉ ANIMALE: BUSINESS OVERVIEW
13.1.7 PHIBRO ANIMAL HEALTH CORPORATION
TABLE 297 PHIBRO ANIMAL HEALTH: BUSINESS OVERVIEW
FIGURE 54 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2021)
13.1.8 HESTER BIOSCIENCES LIMITED
TABLE 298 HESTER BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 55 HESTER BIOSCIENCES: COMPANY SNAPSHOT (2021)
13.1.9 NEOGEN CORPORATION
TABLE 299 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 56 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
13.1.10 HIPRA
TABLE 300 HIPRA: BUSINESS OVERVIEW
13.1.11 BIOGÉNESIS BAGÓ
TABLE 301 BIOGÉNESIS BAGÓ: BUSINESS OVERVIEW
13.1.12 TIANJIN RINGPU BIOTECHNOLOGY CO. LTD.
TABLE 302 TIANJIN RINGPU BIOTECHNOLOGY CO LTD: BUSINESS OVERVIEW
13.1.13 CHINA ANIMAL HUSBANDRY GROUP
TABLE 303 CHINA ANIMAL HUSBANDRY GROUP: BUSINESS OVERVIEW
13.1.14 JINYU BIO-TECHNOLOGY
TABLE 304 JINYU BIO-TECHNOLOGY: BUSINESS OVERVIEW
13.1.15 VAXXINOVA INTERNATIONAL BV
TABLE 305 VAXXINOVA INTERNATIONAL BV: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER COMPANIES
13.2.1 ENDOVAC ANIMAL HEALTH
13.2.2 BRILLIANT BIO PHARMA
13.2.3 APTIMMUNE
13.2.4 INDIAN IMMUNOLOGICALS LTD.
13.2.5 TORIGEN PHARMACEUTICALS, INC.
13.2.6 VEROVACCINES GMBH
13.2.7 INTAS PHARMACEUTICALS
13.2.8 OUROFINO ANIMAL HEALTH
13.2.9 BIOVAC
13.2.10 LABORATOIRE LCV

14 APPENDIX (Page No. - 285)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS